Amgen, Teva hikes show pharma can't blame rebates for all price increases: analyst
admin 6th July 2017 Uncategorised 0Drug companies and pharmacy benefit managers have engaged in a back-and-forth for months over who’s to blame for high drug prices. Now, two pharma companies are increasing cancer drug prices, and one analyst says it’s evidence drugmakers sometimes raise prices simply “because they can.”
More: Amgen, Teva hikes show pharma can't blame rebates for all price increases: analyst
Source: fierce